Genetic Variants Regulate NR1H3 Expression and Contribute to Multiple Sclerosis Risk.

Yan Zhang,Longcai Wang,Haiyang Jia,Mingzhi Liao,Xiaoyun Chen,Jianyong Xu,Yunjuan Bao,Guiyou Liu
DOI: https://doi.org/10.1016/j.jns.2018.04.037
IF: 4.4
2018-01-01
Journal of the Neurological Sciences
Abstract:A recent study analyzed 2053 multiple sclerosis (MS) cases and 799 healthy controls to investigate whether five genetic variants (rs11039149, rs12221497, rs2279238, rs7120118 and rs7114704) in NR1H3 are associated with MS risk. However this study reported negative results. It is very important that the appropriate samples and approach should be used in replication studies, which may provide the correct interpretation of the results. Here, we evaluated the above findings using large-scale MS genome-wide association studies with a total of 27,148 samples including 9772 MS cases and 17,376 controls, and multiple expression quantitative trait loci datasets. The results suggest that rs7120118 and rs2279238 variants are significantly associated with MS risk, and could significantly regulate NR1H3 expression in kinds of human tissues and cells. In summary, these findings provide important supplementary information about the association between NR1H3 variants and MS risk.
What problem does this paper attempt to address?